Tumour targeting of humanised cross-linked divalent-Fab' antibody fragments: a clinical phase I/II study (Q38283180)

1 September 2017

Tumour targeting of humanised cross-linked divalent-Fab' antibody fragments: a clinical phase I/II study (English)

1 reference

1 September 2017

J L Casey

1

1 reference

1 September 2017

M P Napier

2

1 reference

1 September 2017

D J King

3

1 reference

1 September 2017

R B Pedley

4

1 reference

1 September 2017

L C Chaplin

5

1 reference

1 September 2017

N Weir

6

1 reference

1 September 2017

L Skelton

7

1 reference

1 September 2017

A J Green

8

1 reference

1 September 2017

L D Hope-Stone

9

1 reference

1 September 2017

G T Yarranton

10

1 reference

1 September 2017

R H J Begent

11

1 reference

1 September 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

British Journal of Cancer

1 September 2017

1 reference

1 September 2017

86

1 reference

1 September 2017

9

1 reference

1 September 2017

1401-1410

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600198

1 September 2017

0 references

cites work

Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375360

Radioimmunotherapy of metastatic colorectal tumours with iodine-131-labelled antibody to carcinoembryonic antigen: phase I/II study with comparative biodistribution of intact and F(ab')2 antibodies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375360

Making antibodies by phage display technology

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375360

Repeated antitumour antibody therapy in man with suppression of the host response by cyclosporin A.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375360

Mouse/human chimeric monoclonal antibody in man: kinetics and immune response

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375360

Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragments

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375360

Clinical trials with CAMPATH-I and other monoclonal antibodies

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375360

Evaluation of a complementarity-determining region-grafted (humanized) anti-carcinoembryonic antigen monoclonal antibody in preclinical and clinical studies.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375360

Treatment of non-Hodgkin's lymphoma with radiolabeled murine, chimeric, or humanized LL2, an anti-CD22 monoclonal antibody.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375360

The effect of circulating antigen and radiolabel stability on the biodistribution of an indium labelled antibody

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375360

Late renal function following whole abdominal irradiation

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375360

Renal handling of proteins in normal and disease states.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375360

Reshaping human antibodies: grafting an antilysozyme activity

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375360

Antigen-specific human antibodies from mice comprising four distinct genetic modifications

31 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6600198

Circulating antigen: bad or good for immunoscintigraphy?

21 January 2018

1 reference

12 December 2020

Comprehensive pharmacokinetics of a humanized antibody and analysis of residual anti-idiotypic responses

1 reference

12 December 2020

Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors

1 reference

12 December 2020

Operation manual for control of production, preclinical toxicology and phase I trials of anti-tumour antibodies and drug antibody conjugates. Prepared by a Joint Committee of the: Cancer Research Campaign National Institute for Biological Standards

1 reference

12 December 2020

The use of radionuclides for tumor therapy

1 reference

12 December 2020

REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H

1 reference

12 December 2020

Accurate quantification of 131I distribution by gamma camera imaging

1 reference

12 December 2020

Cancer Research Campaign operation manual for control recommendations for products derived from recombinant DNA technology prepared for investigational administration to patients with cancer in phase I trials

1 reference

12 December 2020

Purification of bacterially expressed single chain Fv antibodies for clinical applications using metal chelate chromatography

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6600198

1 reference

Dimensions Publication ID

1 September 2017

0 references

1 reference

1 September 2017

PubMed publication ID

11986771

1 reference